70 / 100 SEO Score

Prof. Dr. Shijia Liu | Clinical Pharmacology | Best Researcher Award

Prof. Dr. Shijia Liu | Clinical Pharmacology | Nanjing University of Chinese Medicine | China

Prof. Dr. Shijia Liu, Research Fellow, Professor at Nanjing University of Chinese Medicine, Academic PhD Supervisor, and Postdoctoral Fellow at the Chicago IIT Research Institute (USA), is a distinguished scholar whose career exemplifies excellence in the field of clinical pharmacology of traditional Chinese medicine, with a strong commitment to bridging laboratory discoveries and clinical applications. Prof. Dr. Shijia Liu completed his doctoral studies with rigorous academic training that provided him with a solid foundation in pharmacology, drug development, and translational medicine, followed by a postdoctoral fellowship in the United States where he refined his expertise in clinical metabolomics and molecular medicine. His professional experience includes serving as Deputy Director of the Pharmacy Department at Jiangsu Provincial Hospital of Traditional Chinese Medicine and leading the National Traditional Chinese Medicine Advantage Specialty Construction Project in Clinical Pharmacy, where he has played an instrumental role in guiding innovation and research translation. Prof. Dr. Shijia Liu research interests are primarily focused on clinical pharmacology, metabolomics, proteomics, biomarker discovery, and the mechanisms underlying disease pathology and treatment efficacy, with a particular emphasis on improving the therapeutic effectiveness of traditional Chinese medicine and developing new diagnostic tools.

Professional Profile: ORCID | Scopus

Selected Publications

  1. Clinical metabolomics reveals potential diagnostic biomarkers in serum samples from patients with generalized ligamentous laxity — 2021 (Citations: 45)

  2. Huangkui capsules regulate tryptophan metabolism to improve diabetic nephropathy through the Keap1/Nrf2/HO-1 pathway — 2020 (Citations: 62)

  3. Metabolomics and proteomics reveal blocking argininosuccinate synthetase 1 alleviates colitis in mice — 2019 (Citations: 58)

  4. Phosphoglycerate kinase 1 contributes to diabetic kidney disease through enzyme-dependent and independent manners — 2018 (Citations: 71)

Prof. Dr. Shijia Liu | Clinical Pharmacology | Best Researcher Award

You May Also Like